about
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trialAssociation of three genetic loci with uric acid concentration and risk of gout: a genome-wide association studyGout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort StudiesReview: Gout: A Roadmap to Approaches for Improving Global OutcomesOIT3 deficiency impairs uric acid reabsorption in renal tubuleAnimal models of chronic pain: Advances and challenges for clinical translation.Gout in immigrant groups: a cohort study in SwedenAssociation of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE Study.Gout in primary care: Can we improve patient outcomes?Serum apoprotein A1 levels are inversely associated with disease activity in gout: From a southern Chinese Han population.Chuanhu anti-gout mixture versus colchicine for acute gouty arthritis: a randomized, double-blind, double-dummy, non-inferiority trial.Characterisation of genome-wide association epistasis signals for serum uric acid in human population isolatesClinical characteristics of gout: a hospital case seriesEfficacy and safety of ozonated autohemotherapy in patients with hyperuricemia and gout: A phase I pilot study.Febuxostat in the management of hyperuricemia and chronic gout: a review.Revisiting the pathogenesis of podagra: why does gout target the foot?Menopause, postmenopausal hormone use and risk of incident goutEpidemiology and management of gout in Taiwan: a nationwide population study.The epidemiology of uric acid and fructose.Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists."Why me? I don't fit the mould … I am a freak of nature": a qualitative study of women's experience of gout.Rhazes' prescriptions in treatment of gout.A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of goutAssociations between interleukin and interleukin receptor gene polymorphisms and risk of gout.Patient and clinical characteristics associated with gout flares in an integrated healthcare system.Latest evidence on gout management: what the clinician needs to knowSafety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.New insights into the epidemiology of gout.Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.Gout in young migrant Filipino women in Israel: a changing epidemiology. Case reports and review of the literature.Recent advances in management of gout.The global burden of gout: estimates from the Global Burden of Disease 2010 study.Association between ABCG2 Q141K polymorphism and gout risk affected by ethnicity and gender: a systematic review and meta-analysis.Inpatient management of gout in a New Zealand hospital: a retrospective audit.Effect of cyclosporine on the pharmacokinetics of colchicine in healthy subjects.Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.Treatment Options for Gout.Musculoskeletal ultrasonography in the diagnosis of acute crystalline synovitis.Investigation into the association between P2RX7 gene polymorphisms and susceptibility to primary gout and hyperuricemia in a Chinese Han male population.
P2860
Q21195361-06EA4143-CD67-449C-A7DD-44C9A4604D6AQ24318894-1B781336-9709-4B4C-8D18-4234ED3E0C35Q26800933-6421064B-33D9-435C-8788-DD898972A37CQ28076018-06678F13-9DFC-4643-B4E4-A34536881995Q28509003-2D7309AC-55F0-46AF-9566-203711DB7E4EQ30249165-0ADEEA24-3FA4-47BA-9DCC-9CE3F6C4D678Q33592015-AF2D70CA-5F5C-4739-A404-7F31D0BD065AQ33621145-3061B4F3-D6D8-4040-862C-F3B4DBF52B15Q33622431-8F02C799-4A8A-4480-A9B7-142010D483CFQ33627261-9DADDFEB-04F7-4DE7-9C98-EE71557E5047Q33843844-A5277056-87BD-40B2-B067-5CAB113184FEQ34008978-E79E68BD-EF26-4EBE-912F-5889B142E0C5Q34220881-164C579E-D81A-4B7F-A368-E160EC0E578CQ34292345-9BE66C20-43CB-47F8-BFD6-4D50F0B3ED68Q34658300-FE005205-6612-4228-BC9F-43351DA69B07Q35052925-D5F84D08-6383-4A64-B67E-E02362A084E9Q35125409-531CDAD4-9462-4AEC-B527-20DC3BBF564BQ35127836-96222A1A-1182-46F0-9BA3-EE4F4DA0078EQ35393502-AD6A8556-A975-4B1A-AED0-C1A37D301F3CQ35746133-E72C34DF-D980-4DB6-BCFA-4286EE782818Q35879890-43ECD034-8C28-4B4F-8396-FA7998FD0358Q36022665-3E262045-2833-4AF7-97E9-35C4D2AC5326Q36042495-D44E5A00-433B-40DA-B9E3-61F3A08B2E4CQ36099740-18087D5E-42AC-4824-979F-A17AD81A2BCCQ36177440-E4E689BE-7056-4D52-9AAF-678737EFD969Q36515484-3BEF28AD-0F68-40C8-BE22-81A1C8F09ABCQ36981450-AAB9B650-2586-415C-8D2A-C2B217CBBDCFQ37127097-91889DDA-C1F7-42C5-9841-0A11ADFDF102Q37485331-E606A00F-2662-4E0E-B59B-BCA2B28FBBC2Q37591158-BABF3369-4403-466C-A6BC-ECA31C75FAF7Q37611643-92999836-8316-4904-A431-B44B60E971F4Q37971360-A03A6EC8-74A7-4936-A178-45A6857A9509Q38192917-AD4BF1E5-F311-4B4D-A17B-30FDFD2B14C1Q38339494-E07C3247-5BC4-497D-A91C-9EC2CCD1F61BQ38420885-F2AC22ED-992A-468D-8CA0-41FCEBDAA300Q38465517-2EEA67D5-C4C1-446A-AE46-EA74AA57E831Q38600529-8DB536FC-8100-493D-A00F-9A42065065D5Q38691902-8AA0A6B3-13BC-4A9E-809F-A7759926AC8AQ38903643-6163FC45-2A01-42B3-A542-68989AB2E229Q38938117-FA6DB47F-0E47-481C-ABD6-1A69BBF6FC99
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The changing epidemiology of gout.
@en
type
label
The changing epidemiology of gout.
@en
prefLabel
The changing epidemiology of gout.
@en
P356
P1476
The changing epidemiology of gout.
@en
P2093
Edward Roddy
P2888
P304
P356
10.1038/NCPRHEUM0556
P577
2007-08-01T00:00:00Z
P6179
1021460304